Alphamab Oncology (09966) Announces Monthly Return on Movements in Securities for November 2025

Bulletin Express12-04

Alphamab Oncology (09966) submitted a monthly return, dated December 4, 2025, detailing its authorized and issued share movements for November 2025. The authorized share capital remained at 25,100,000,000 ordinary shares, each with a par value of USD0.000002, totaling USD50,200.

At the close of November, there were 969,310,697 issued shares (excluding treasury shares) and 4,983,000 treasury shares, resulting in a total of 974,293,697 shares. This represents a decrease of 764,000 issued shares in circulation compared to the preceding month, primarily due to the repurchase of 910,000 shares at prices ranging from HKD9.3946 to HKD9.7708 per share on November 7 and November 17, 2025, which were carried into treasury. Meanwhile, 146,000 new shares were issued upon exercise of share options, raising HKD787,164.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1167152262?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-04 17:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1167152262","market":"us","top_or_hot":-1,"title":"Alphamab Oncology (09966) Announces Monthly Return on Movements in Securities for November 2025","media":"Bulletin Express","content":"<p>Alphamab Oncology (09966) submitted a monthly return, dated December 4, 2025, detailing its authorized and issued share movements for November 2025. The authorized share capital remained at 25,100,000,000 ordinary shares, each with a par value of USD0.000002, totaling USD50,200.</p>\n<p>At the close of November, there were 969,310,697 issued shares (excluding treasury shares) and 4,983,000 treasury shares, resulting in a total of 974,293,697 shares. This represents a decrease of 764,000 issued shares in circulation compared to the preceding month, primarily due to the repurchase of 910,000 shares at prices ranging from HKD9.3946 to HKD9.7708 per share on November 7 and November 17, 2025, which were carried into treasury. Meanwhile, 146,000 new shares were issued upon exercise of share options, raising HKD787,164.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alphamab Oncology (09966) Announces Monthly Return on Movements in Securities for November 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlphamab Oncology (09966) Announces Monthly Return on Movements in Securities for November 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-12-04 17:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Alphamab Oncology (09966) submitted a monthly return, dated December 4, 2025, detailing its authorized and issued share movements for November 2025. The authorized share capital remained at 25,100,000,000 ordinary shares, each with a par value of USD0.000002, totaling USD50,200.</p>\n<p>At the close of November, there were 969,310,697 issued shares (excluding treasury shares) and 4,983,000 treasury shares, resulting in a total of 974,293,697 shares. This represents a decrease of 764,000 issued shares in circulation compared to the preceding month, primarily due to the repurchase of 910,000 shares at prices ranging from HKD9.3946 to HKD9.7708 per share on November 7 and November 17, 2025, which were carried into treasury. Meanwhile, 146,000 new shares were issued upon exercise of share options, raising HKD787,164.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09966","symbol_name":"康宁杰瑞制药-B","start_time":0,"source_url":"","article_id":"1167152262","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1167152262","pubTimestamp":1764839733,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Alphamab Oncology (09966) submitted a monthly return, dated December 4, 2025, detailing its authorized and issued share movements for November 2025. The authorized share capital remained at...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09966":"康宁杰瑞制药-B"},"translate_title":"康宁杰瑞肿瘤(09966)公布2025年11月证券变动月报表","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09966":1},"content_text":"Alphamab Oncology (09966) submitted a monthly return, dated December 4, 2025, detailing its authorized and issued share movements for November 2025. The authorized share capital remained at 25,100,000,000 ordinary shares, each with a par value of USD0.000002, totaling USD50,200.\nAt the close of November, there were 969,310,697 issued shares (excluding treasury shares) and 4,983,000 treasury shares, resulting in a total of 974,293,697 shares. This represents a decrease of 764,000 issued shares in circulation compared to the preceding month, primarily due to the repurchase of 910,000 shares at prices ranging from HKD9.3946 to HKD9.7708 per share on November 7 and November 17, 2025, which were carried into treasury. Meanwhile, 146,000 new shares were issued upon exercise of share options, raising HKD787,164.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1167152262","isCrawlerRequest":true}